world
current
face
pandem
novel
coronaviru
diseas
covid
caus
sever
acut
respiratori
syndrom
coronaviru
vaccin
cure
predict
develop
safe
effect
vaccin
prevent
take
one
year
month
time
like
sever
hundr
thousand
million
peopl
may
infect
rapidli
grow
number
case
death
around
world
emerg
threat
requir
nimbl
target
mean
protect
sinc
coronavirus
caus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
abl
suddenli
transfer
human
divers
anim
host
act
viral
reservoir
press
need
develop
method
combat
potenti
coronavirus
may
emerg
futur
recent
report
show
two
strain
l
differ
genom
sequenc
circul
like
evolv
highlight
need
pancoronaviru
vaccin
strategi
novel
coronaviru
caus
belong
famili
positivesens
rna
virus
typic
infect
upper
lower
respiratori
track
caus
diseas
direct
cytotox
effect
induct
host
cytokin
diseas
life
cycl
like
similar
close
relat
coronavirus
viru
caus
sar
viru
enter
cell
releas
rna
genom
cytoplasm
synthes
negativesens
genom
subgenom
rna
viral
mrna
new
copi
posit
sens
viral
genom
synthes
fig
wherea
tradit
vaccin
work
prime
human
immun
system
recogn
viral
protein
weaken
virus
decreas
viral
entri
cell
altern
antivir
approach
propos
reli
crisprbas
system
recogn
degrad
intracellular
viral
genom
result
viral
mrna
fig
target
positivesens
genom
viral
mrna
simultan
degrad
viral
genom
templat
replic
viral
gene
express
would
expect
robustli
limit
viral
replic
inhibit
rna
virus
human
cell
use
system
deriv
ruminococcu
flavefacien
recent
discov
rnaguid
rna
endonucleas
employ
crisprassoci
rna
crrna
contain
customiz
nucleotid
nt
spacer
sequenc
direct
protein
specif
rna
molecul
target
rna
degrad
high
catalyt
activ
mammalian
cell
provid
potenti
mechan
target
specif
viral
rna
genom
degrad
viral
gene
express
inhibit
small
size
amino
acid
high
specif
strong
catalyt
activ
chose
rather
protein
target
destroy
rna
virus
includ
influenza
viru
iav
work
develop
prophylact
antivir
crispr
human
cell
pacman
strategi
form
genet
intervent
target
iav
potenti
sequenc
coronavirus
creat
bioinformat
pipelin
defin
conserv
region
across
genom
target
region
use
viral
genom
degrad
viral
gene
inhibit
time
paper
submiss
wide
avail
laboratori
strain
therefor
test
approach
use
synthes
fragment
well
live
iav
design
screen
panel
crrna
pool
target
conserv
viral
region
defin
effect
crrna
demonstr
abil
approach
cleav
fragment
reduc
replic
iav
human
lung
epitheli
cell
bioinformat
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
analysi
reveal
group
six
crrna
target
sequenc
coronavirus
well
group
crrna
abl
target
sequenc
coronavirus
potenti
pancoronaviru
protect
use
offer
altern
complementari
approach
tradit
pharmaceut
vaccin
use
crrna
pool
target
differ
region
viru
differ
strain
coronaviru
system
could
possibl
buffer
viral
evolut
escap
well
enabl
rapid
develop
deploy
emerg
virus
combin
effect
deliveri
platform
pacman
promis
strategi
combat
coronavirus
includ
caus
also
broad
rang
genera
virus
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
creat
effect
specif
crrna
sequenc
target
cleav
first
perform
bioinformat
analysi
align
publish
genom
patient
sarscov
merscov
genom
singlenucleotid
resolut
level
singlestrand
rna
genom
nucleotid
encod
put
function
open
read
frame
analysi
found
region
high
conserv
sarscov
merscov
genom
fig
two
highlyconserv
region
respect
contain
rnadepend
rna
polymeras
rdrp
gene
polypeptid
region
maintain
prolifer
coronavirus
nucleocapsid
n
gene
end
genom
encod
capsid
protein
viral
packag
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
target
highli
conserv
region
gener
silico
collect
possibl
crrna
supplement
fig
exclud
crrna
either
predict
potenti
offtarget
bind
mismatch
human
transcriptom
polyt
ts
sequenc
may
prevent
crrna
express
obtain
collect
crrna
supplement
tabl
design
synthes
crrna
crrna
target
conserv
sequenc
rdrp
n
gene
supplement
tabl
rational
dens
target
two
region
significantli
reduc
viral
genom
rna
mrna
templat
express
essenti
viral
protein
minim
risk
loss
target
activ
mutat
escap
evalu
whether
effect
target
sequenc
creat
two
report
express
synthes
fragment
fuse
gfp
fig
supplement
tabl
appear
mainli
infect
respiratori
tract
cell
patient
chose
use
human
lung
epitheli
cell
model
cell
line
creat
stabl
cell
line
express
lentivir
infect
follow
sort
mcherri
marker
coexpress
fig
first
investig
region
fragment
suscept
target
cleavag
transfect
transduc
report
cell
transduc
pool
four
crrna
target
either
rdrp
n
gene
region
fig
see
method
chose
evalu
effect
system
use
pool
crrna
sinc
context
live
viral
infect
would
prevent
possibl
escap
inhibit
due
mutat
involv
singl
crrna
target
site
total
ten
group
test
crrna
supplement
tabl
twentyfour
hour
report
transfect
perform
flow
cytometri
examin
level
gfp
protein
express
collect
rna
cell
perform
quantit
realtim
pcr
qrtpcr
examin
mrna
transcript
abund
observ
rdrptarget
crrna
pool
abl
repress
report
express
extent
compar
control
one
pool
target
middl
tabl
design
crrna
sequenc
supplement
tabl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
rdrp
region
genom
coordin
abl
repress
gfp
p
fig
b
supplement
tabl
one
pool
n
genetarget
crrna
genom
coordin
abl
substanti
repress
gfp
caus
decreas
express
p
fig
b
supplement
tabl
qrtpcr
analysi
show
consist
result
rna
level
inhibit
respect
report
mrna
abund
p
p
fig
b
supplement
tabl
variat
abil
differ
crrna
pool
repress
report
like
due
rna
secondari
structur
inher
genom
differ
bind
affin
crrna
sequenc
composit
tabl
p
valu
ce
label
group
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
next
independ
valid
perform
adjac
crrna
pool
introduc
via
lentivir
transduct
argu
approach
lentivirusderiv
rna
serv
pacman
target
prior
lentiviru
integr
dna
mimic
crrna
target
condit
would
appli
natur
infect
test
select
crrna
pool
includ
best
group
one
less
effici
group
lentivir
multipl
infect
moi
result
reveal
similar
pattern
transfect
experi
best
group
abl
repress
report
p
respect
fig
qrtpcr
analysi
also
show
consist
result
repress
rna
abund
p
respect
fig
valid
effect
repress
report
cotransfect
report
pool
crrna
tile
along
whole
fragment
compar
pool
nontarget
control
crrna
tabl
found
rdrptarget
crrna
abl
repress
gfp
p
ntarget
crrna
abl
repress
gfp
p
fig
also
analysi
extent
express
crrna
affect
gfp
report
inhibit
analysi
reveal
inhibit
sensit
crrna
concentr
sampl
lower
express
moder
decreas
inhibitori
activ
fig
thu
maintain
high
level
crrna
concentr
like
determin
factor
effect
sequenc
target
cleavag
data
togeth
suggest
pacman
effect
system
target
degrad
sequenc
human
cell
proper
design
crrna
import
obtain
high
effici
inhibit
sinc
yet
access
live
viru
proofofconcept
elect
test
strategi
inhibit
iav
rna
viru
similar
tropism
respiratori
tract
epitheli
cell
contrast
singl
continu
rna
genom
iav
genom
contain
negativesens
rna
segment
play
import
role
packag
viral
rna
bud
virion
creat
crrna
target
broad
rang
iav
strain
align
complet
iav
genom
retriev
influenza
research
databas
search
conserv
region
supplement
tabl
analysi
work
other
show
segment
end
highli
conserv
segment
segment
end
potenti
attract
region
target
potenti
inhibit
broad
rang
iav
strain
previou
evid
interf
packag
one
segment
encod
segment
end
decreas
packag
effici
segment
overal
virion
packag
use
sequenc
represent
differ
strain
influenza
design
crrna
could
robust
across
mani
differ
iav
strain
possibl
bioinformat
analysi
result
crrna
target
highli
conserv
genom
region
iav
segment
total
crrna
supplement
tabl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
test
effici
iavtarget
crrna
perform
screen
crrna
pool
stabl
cell
line
determin
effect
inhibit
iav
infect
fig
transfect
pool
crrna
target
given
iav
genom
segment
two
day
crrna
transfect
cell
challeng
strain
iav
apuerto
engin
express
mneongreen
gene
fluoresc
report
protein
hereaft
refer
moi
approxim
hour
postchalleng
cell
analyz
iav
infect
flow
cytometri
microscopi
examin
percentag
cell
mneon
posit
segmenttarget
crrna
pool
calcul
foldchang
compar
cell
transfect
pool
nontarget
crrna
crrna
crrna
pool
target
segment
deliv
consist
robust
result
across
differ
moi
reduct
moi
reduct
moi
fig
addit
segment
pool
also
show
moder
consist
inhibit
verifi
inhibitori
effect
test
lower
moi
show
better
inhibit
iav
across
sampl
eg
reduct
use
crrna
target
fig
confirm
consist
inhibitori
activ
iav
target
two
segment
possibl
trend
greater
inhibit
lower
viral
titer
suggest
pacman
could
particularli
effect
strategi
prevent
new
infect
typic
occur
exposur
low
level
viru
character
crrna
pool
encod
gene
neuraminidas
na
releas
bud
virion
host
cell
perform
microscopi
quantif
mneon
cell
found
mneon
express
reduc
p
p
moi
respect
crrna
fig
trend
corrobor
flow
cytometri
fig
togeth
data
show
pacman
abl
target
highli
conserv
viral
region
robustli
inhibit
viral
replic
human
lung
epitheli
cell
past
two
decad
multipl
variant
coronaviru
includ
caus
sar
mer
emerg
anim
reservoir
infect
human
time
caus
signific
diseas
fatal
thu
design
strategi
could
broadli
prevent
target
viral
threat
includ
coronaviru
strain
current
resid
anim
would
valuabl
resourc
ask
whether
possibl
design
minim
number
crrna
could
target
major
known
coronavirus
found
human
anim
analyz
known
coronaviru
genom
identifi
possibl
crrna
target
genom
end
approxim
million
possibl
crrna
fig
refin
list
defin
smallest
number
crrna
could
target
known
coronaviru
genom
zero
mismatch
found
two
crrna
could
target
coronaviru
genom
includ
caus
sar
mer
crrna
abl
target
coronaviru
genom
crrna
cover
sequenc
coronavirus
mismatch
fig
supplement
tabl
abil
use
rel
small
number
crrna
broadli
target
coronaviru
strain
highlight
uniqu
approach
contrast
tradit
pharmaceut
vaccin
approach
resourc
provid
map
show
top
crrna
target
coronaviru
phylogenet
tree
fig
red
box
beta
coronavirus
genu
virus
caus
sar
mer
mostli
cover
crrna
crrna
genera
cover
three
plu
remain
crrna
altogeth
target
known
human
coronaviru
broad
coverag
anim
coronavirus
minim
set
six
crrna
also
includ
one
crrna
design
valid
recent
work
analyz
genom
indic
two
major
type
l
exist
differ
viral
signatur
sequenc
verifi
whether
target
l
strain
retriev
set
recent
sequenc
sequenc
global
initi
share
influenza
data
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
gisaid
notabl
target
genom
one
sequenc
carri
singl
mismatch
mutat
supplement
tabl
suggest
approach
robustli
target
multipl
strain
also
suggest
potenti
need
use
pool
crrna
avoid
mutat
escap
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
emerg
natur
bacteri
defens
bacteriophag
power
antivir
system
abl
use
sequencespecif
crrna
protect
host
bacteri
cell
infect
repurpos
rnaguid
rna
endonucleas
activ
mammalian
cell
emerg
viral
target
iav
pacman
strategi
expand
applic
system
addit
use
diagnost
sherlock
livecel
imag
prior
work
show
system
could
inhibit
ssrna
virus
includ
influenza
consist
observ
high
effici
report
iav
inhibit
use
pacman
approach
demonstr
genet
target
effect
target
cleav
rna
sequenc
fragment
iav
lung
epitheli
cell
cultur
bioinformat
analysi
also
suggest
minim
pool
crrna
abl
target
sequenc
coronavirus
strategi
proofofconcept
requir
test
use
replicationcompet
virus
valid
anim
model
clinic
test
human
repres
uniqu
approach
implement
rapid
broad
antivir
defens
human
emerg
pathogen
effect
vaccin
iav
found
highli
conserv
region
viral
genom
target
case
genom
region
encod
rdrp
nucleocapsid
protein
essenti
coronaviru
replic
function
rdrp
respons
catalyz
replic
viral
mrna
nucleocapsid
bind
genom
rna
protect
serv
one
two
main
structur
protein
virion
target
inhibit
protein
could
outsiz
effect
disabl
viru
product
function
addit
reduc
viral
load
degrad
viral
genom
iav
crrna
show
best
viral
inhibit
target
conserv
end
segment
encod
neuraminidas
na
viral
surfac
protein
essenti
mediat
bud
new
virion
prior
mutat
analysi
shown
mutat
packag
signal
one
segment
end
lead
decreas
packag
segment
indic
cooper
mechan
packag
iav
genom
thu
inhibit
singl
iav
genom
segment
could
reduc
overal
packag
iav
synergist
fashion
notabl
rdrp
gene
iav
na
gene
target
studi
also
target
two
antivir
drug
remdesivir
oseltamivir
remdesivir
creat
gilead
scienc
develop
code
rdrp
inhibitor
develop
treat
ebola
marburg
viru
infect
report
antivir
activ
mer
sar
remdesivir
alreadi
administ
compassion
use
request
clinic
trial
use
alreadi
start
us
clinic
trial
id
china
oseltamivir
also
known
tamiflu
antivir
medic
treat
prevent
iav
act
inhibitor
na
therebi
prevent
egress
new
viral
particl
interest
see
drug
could
use
combin
pacman
synergist
crippl
viral
function
replic
demonstr
pacman
system
abl
exhibit
strong
repress
viral
sequenc
vitro
set
must
coupl
effect
vivo
deliveri
system
therapeut
use
sever
potenti
strategi
could
employ
transient
vivo
express
crispr
compon
cognat
crrna
could
deliv
rna
within
polym
lipid
nanoparticl
perhap
chemic
alter
increas
stabil
addit
dnabas
liposom
deliveri
strategi
recent
develop
hedg
platform
also
attract
yet
anoth
strategi
would
deliv
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
ribonucleoprotein
complex
contain
purifi
assembl
crrna
could
potenti
use
therapeut
prophylact
measur
deliveri
barrier
overcom
strategi
like
abl
use
therapeut
mani
potenti
benefit
tradit
vaccin
tradit
vaccin
reli
prime
immun
system
exposur
viral
protein
peptid
often
deriv
surfac
protein
exhibit
high
rate
mutat
increas
chanc
viral
evas
host
immun
respons
contrast
demonstr
genet
strategi
abl
target
highli
conserv
region
would
expect
make
much
unlik
viru
escap
inhibit
mutat
addit
abil
process
crrna
crrna
array
mean
multipl
crrna
target
differ
region
eg
fig
fig
could
deliv
simultan
reduc
chanc
viral
escap
advantag
demonstr
potenti
pancoronaviru
strategi
target
virus
circul
human
also
current
found
anim
reservoir
might
transfer
human
caus
diseas
crrna
target
virus
test
valid
ever
infect
human
greatli
acceler
develop
countermeasur
futur
emerg
threat
summari
pacman
strategi
repres
potenti
power
new
approach
inhibit
viral
function
replic
envis
could
use
divers
array
circul
emerg
viral
threat
complet
assembl
download
http
februari
coronavirina
complet
genom
sequenc
download
vipr
viru
pathogen
resourc
databas
februari
exclud
short
genom
collect
total
coronavirina
viru
genom
genom
sequenc
download
gisaid
global
initi
share
influenza
data
http
wwwgisaidorg
develop
full
comput
workflow
design
crrna
system
design
possibl
crrna
three
pathogen
rna
virus
sarscov
merscov
refer
genom
sarscov
merscov
along
genom
deriv
patient
first
align
mafft
use
auto
flag
crrna
candid
identifi
use
slide
window
extract
nt
sequenc
perfect
ident
among
genom
annot
crrna
candid
number
mismatch
rel
sarscov
merscov
genom
well
gc
content
crrna
candid
select
perfect
match
genom
mismatch
sarscov
merscov
sequenc
character
specif
crrna
ensur
crrna
target
sequenc
human
transcriptom
use
bowti
align
crrna
human
transcriptom
includ
noncod
rna
remov
crrna
map
human
transcriptom
fewer
mismatch
maxim
vertic
coverag
pool
crrna
target
maxim
set
coronavirina
virus
minim
set
crrna
slide
window
use
extract
uniqu
nt
sequenc
coronavirina
genom
yield
uniqu
crrna
candid
hash
tabl
use
map
crrna
candid
number
coronavirina
genom
target
perfect
match
greedi
algorithm
use
identifi
minim
set
cover
crrna
iter
crrna
sort
descend
order
number
genom
target
crrna
target
genom
ad
minim
set
crrna
genom
target
remov
hash
tabl
valu
multipl
crrna
tie
target
genom
crrna
rank
length
quantiti
stretch
repeat
nucleotid
lowest
rank
crrna
ie
one
fewest
shortest
stretch
repeat
nucleotid
ad
set
minim
crrna
use
approach
set
crrna
identifi
abl
target
coronavirina
viru
genom
includ
phylogenet
tree
associ
annot
gener
interact
tree
life
itol
http
itolembld
complet
genom
sequenc
align
sarscov
merscov
ncbi
refseq
sequenc
mafft
use
auto
flag
align
visual
use
geneiou
prime
softwar
geneiou
http
wwwgeneiouscom
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
consensu
nucleotid
share
nongap
charact
given
posit
assign
posit
align
everi
posit
consensu
nucleotid
percent
conserv
posit
calcul
percentag
sequenc
match
consensu
posit
aid
interpret
result
plot
percentag
conserv
smooth
use
move
averag
window
size
bp
center
posit
posit
correspond
gap
charact
refer
sequenc
omit
crrna
plasmid
clone
use
standard
restrictionlig
clone
forward
revers
oligo
spacer
idt
anneal
insert
backbon
use
dna
ligas
neb
assembl
oligo
either
insert
phr
backbon
obtain
modifi
addgen
respect
spacer
sequenc
crrna
found
supplement
tabl
clone
report
phrpgkscfv
digest
gel
purifi
pgk
promot
sfgfp
pcr
amplifi
gel
purifi
fragment
synthes
integr
dna
technolog
idt
last
pgk
sfgfp
fragment
insert
linear
vector
use
infus
clone
takara
bio
day
one
confluent
dish
corn
cell
seed
three
dish
corn
day
cell
confluent
time
transfect
cell
lentiviru
precipit
solut
alstem
ad
precipit
per
manufactur
protocol
one
well
plate
corn
cell
confluenc
transduc
precipit
lentiviru
day
growth
cell
supernat
contain
viru
remov
cell
expand
cell
sort
mcherri
cell
use
soni
cell
sorter
tabl
day
cell
switch
fresh
medium
puromycin
ugml
twentyfour
hour
puromycin
select
cell
transfect
crrna
challeng
report
plasmid
report
lentiviru
twentyfour
hour
transfect
hour
transduct
cell
test
use
flow
cytometri
beckmancoult
cytoflex
qrtpcr
biorad
authorfund
right
reserv
reus
allow
without
permiss
mneon
iav
gener
insert
mneon
fluoresc
gene
segment
apuerto
strain
nichola
heaton
lab
duke
univers
previous
describ
viru
propag
chicken
egg
harvest
allanto
fluid
contain
viru
titer
use
mdck
plaqu
assay
frozen
aliquot
later
use
cell
plate
two
mm
dish
follow
day
cell
transfect
pool
crrna
target
iav
genom
nontarget
control
supplement
tabl
ml
optimem
reduc
serum
media
miru
reagent
approxim
hour
transfect
cell
dissoci
replat
plate
densiti
cellswel
incub
overnight
flow
cytometri
perform
excess
cell
quantifi
transfect
effici
cell
challeng
overnight
mneongreen
express
apuerto
moi
uninfect
cell
includ
neg
control
independ
twotail
test
use
calcul
p
valu
statist
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
develop
crispr
prophylact
strategi
combat
novel
coronaviru
influenza
abbott
et
al
manuscript
realtim
qrtpcr
perform
quantifi
rna
abund
sampl
total
rna
isol
use
rneasi
plu
mini
kit
qiagen
cat
follow
cdna
synthesi
use
iscript
cdna
synthesi
kit
biorad
cat
qrtpcr
primer
order
integr
dna
technolog
idt
quantit
pcr
perform
use
primepcr
assay
sybr
green
master
mix
biorad
run
biorad
realtim
system
touch
thermal
cycler
accord
manufactur
instruct
cq
valu
use
quantifi
rna
abund
rel
abund
fragment
normal
gapdh
intern
control
microscopi
experi
perform
nikon
tie
invert
confoc
microscop
equip
andor
ixon
emccd
camera
nm
nm
nm
nm
laser
use
plan
apo
air
object
na
imag
taken
use
ni
element
version
softwar
microscopi
iav
experi
perform
keyenc
microscop
equip
gfp
texa
red
filter
use
obtain
imag
object
len
cell
express
transfect
crrna
challeng
mneon
viru
wash
pb
treat
trypsin
edta
fix
paraformaldehyd
pb
minut
cell
wash
fac
buffer
pb
bsa
edta
bd
accuri
plu
flow
cytomet
use
collect
raw
data
raw
data
process
cytobank
bd
softwar
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
